Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
STERILE WATER vs PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Water serves as a solvent and vehicle for drug administration; it has no intrinsic pharmacological activity.
Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological p H.
Reconstitution of powdered medications,Dilution of intravenous medications,Flushing of intravenous lines,Hydration (when combined with electrolytes)
Intravenous replacement of intravascular volume and electrolytes in patients with normal or slightly acidic p H,Maintenance of fluid and electrolyte balance during surgery or in critical care,Correction of hypovolemia when isotonic fluid administration is appropriate
50-100 m L intravenous bolus as a vehicle for drug reconstitution or for hydration; frequency as needed for specific clinical indication.
Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 m L over 1-2 hours.
1.5–3.5 hours; water turnover depends on physiological state; clinical context: equilibrates rapidly with total body water
Not applicable; components follow first-order kinetics with rapid redistribution. Lactate half-life ~15-30 minutes (hepatic metabolism).
Not metabolized; excreted unchanged primarily by the kidneys.
Acetate is metabolized primarily in the liver and muscles to bicarbonate.
Renal: >99% as water; fecal: negligible; biliary: negligible
Primarily renal; >95% of infused ions (sodium, chloride, lactate, calcium, magnesium) are excreted unchanged in urine. Biliary/fecal elimination negligible (<1%).
0% (water is not protein-bound)
Negligible (<1%); ions are free in plasma (no significant protein binding).
0.6 L/kg (approximates total body water; Vd ~42 L in 70 kg adult)
0.4 L/kg; distributes mainly in extracellular fluid (ECF).
Intravenous: 100%; Oral: >95% (essentially complete absorption)
100% (intravenous); not absorbed orally.
No dose adjustment required; however, careful monitoring of fluid balance in patients with renal impairment to avoid fluid overload.
Contraindicated in oliguric or anuric renal failure; in GFR <30 m L/min, avoid use or monitor electrolytes closely; no specific GFR-based dose adjustment.
No dose adjustment required; sterile water does not undergo hepatic metabolism.
No specific Child-Pugh based adjustments; use with caution in hepatic impairment due to risk of fluid overload.
Dose based on patient weight and clinical need; typical fluid maintenance: 100 m L/kg/day for first 10 kg, plus 50 m L/kg/day for next 10 kg, plus 20 m L/kg/day for weight above 20 kg; administered intravenously.
Weight-based dosing: 5-10 m L/kg intravenous infusion over 1-2 hours, not to exceed 30 m L/kg/day.
Use with caution due to potential for fluid overload; adjust volume based on renal function and cardiovascular status; typical starting dose 25-50 m L intravenous bolus.
Use with caution due to increased risk of fluid overload and electrolyte imbalance; adjust rate and volume based on renal function and comorbidities, typical initial dose 500 m L over 2-3 hours.
None.
None.
Use only sterile water for injection; hypotension and electrolyte disturbances if used in large volumes without electrolytes; hemolysis if administered intravenously without isotonicity.
Use with caution in patients with severe renal impairment, heart failure, or conditions associated with sodium retention,Monitor serum electrolytes, fluid balance, and acid-base status during prolonged administration,Risk of volume overload in patients with compromised cardiac or renal function,Contains aluminum; may be toxic with prolonged use in patients with renal impairment
Hypersensitivity to any component; do not use for intravenous injection without first making isotonic by adding solutes (except for reconstitution followed by dilution).
Hypersensitivity to any component,Severe hypernatremia or severe hyperchloremia,Severe metabolic alkalosis,Patients with contraindications to intravenous fluid administration
No known food interactions.
No food interactions are relevant as Physiosol p H 7.4 is not ingested. It is used exclusively for topical irrigation during medical procedures.
No known teratogenic effects in any trimester; sterile water is not pharmacologically active and does not cross the placenta in quantities that would produce fetal effects. Risk classification: FDA Category A (if considered a drug) or generally recognized as safe.
Physiosol p H 7.4 (balanced electrolyte solution) is considered low risk for teratogenicity. There are no known fetal risks associated with its use in any trimester, as it is a physiological solution. However, large volumes or rapid administration could theoretically cause maternal electrolyte imbalances, which may indirectly affect the fetus.
Compatible with breastfeeding; water is a normal constituent of breast milk and maternal administration does not increase risk. M/P ratio: 1.0 (approximate, as water distributes equally in body fluids).
Physiosol p H 7.4 is compatible with breastfeeding. No M/P ratio is available; however, components are normal plasma constituents and unlikely to be excreted into breast milk in clinically significant amounts.
No dose adjustment required; pharmacokinetics of water are unchanged in pregnancy. Standard dosing based on clinical need (e.g., hydration, dilution of medications).
No specific dose adjustment is required for pregnancy. However, consider increased plasma volume and glomerular filtration rate in pregnancy; standard dosing is appropriate, but monitor for volume overload.
Sterile water is used for dilution or reconstitution of medications before injection. It is not for direct intravenous administration without tonicity adjustment. Use within 2 hours after opening to minimize contamination risk.
Physiosol p H 7.4 is a balanced crystalloid solution used for irrigation, not for systemic administration. In the operating room, it is preferred for peritoneal lavage due to its neutral p H, which minimizes tissue irritation. Do not use for intravenous infusion; verify labeling to avoid confusion with IV solutions. Warm to body temperature before use to prevent hypothermia during large-volume irrigation.
This product is not for direct injection; it must be mixed with medication by a healthcare professional.,Do not use if solution is cloudy or contains particulates.,Store at room temperature away from moisture and heat.
This solution is used to rinse body cavities during surgery, not for intravenous use.,You may feel a cooling sensation during irrigation; this is normal.,Report any signs of infection at the surgical site, such as redness, swelling, or discharge.,Do not attempt to use this solution at home; it is for hospital use only.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about STERILE WATER vs PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER, answered by our medical review team.
STERILE WATER is a Irrigation Solution that works by Water serves as a solvent and vehicle for drug administration; it has no intrinsic pharmacological activity.. PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is a Irrigation Solution that works by Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological p H.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between STERILE WATER and PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER depend on the specific clinical indication. These are both Irrigation Solution agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of STERILE WATER is: 50-100 m L intravenous bolus as a vehicle for drug reconstitution or for hydration; frequency as needed for specific clinical indication.. The standard adult dose of PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is: Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 m L over 1-2 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between STERILE WATER and PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. STERILE WATER is classified as Category C. No known teratogenic effects in any trimester; sterile water is not pharmacologically active and does not cross the placenta in quantities that would produce fetal effects. Risk cl. PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is classified as Category C. Physiosol pH 7.4 (balanced electrolyte solution) is considered low risk for teratogenicity. There are no known fetal risks associated with its use in any trimester, as it is a phys. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.